DOI: 10.1055/s-00035331

Revista Urología Colombiana / Colombian Urology Journal

LinksClose Window

References

Motzer RJ, Barrios CH, Kim TM. et al.
Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma.

J Clin Oncol 2014;
32 (25) 2765-2772
http://www.ncbi.nlm.nih.gov/pubmed/25049330 [Internet]

Download Bibliographical Data

Access:
Access:

We do not assume any responsibility for the contents of the web pages of other providers.